PALO ALTO, Calif., Oct. 23, 2019 /PRNewswire/ -- In an effort to
expand the availability of adaptive radiotherapy to patients at its
hospital, Amsterdam UMC has placed an order for six Varian
Ethos™ therapy solutions. Ethos therapy is an
artificial intelligence (AI)-driven holistic solution designed to
increase the capability, flexibility and efficiency of
radiotherapy. Ethos therapy is designed to deliver an entire
adaptive treatment in a typical 15-minute timeslot, from patient
setup through treatment delivery. The first system at Amsterdam UMC
is scheduled to be installed and treating patients by early
2020.
"Adaptive therapy is one of the most important developments in
the field of radiotherapy, and the new Ethos solution will greatly
increase our ability to offer this advanced treatment to patients,"
said Prof.dr. Ben Slotman, head of
the departments of Radiation Oncology. "We were looking for a
solution that could deliver an adaptive treatment in a typical
15-minute timeslot and could be placed in our current treatment
rooms without the need for structural adjustments. Ethos was a
perfect fit."
"We are very proud that our longtime clinical partner Amsterdam
UMC has selected the Ethos therapy solution to greatly expand their
adaptive radiotherapy capability," said Chris Toth, president, Varian Oncology Systems.
"Since its introduction just over a month ago, the Ethos therapy
solution has been recognized by leading clinics around the world as
a game changer that is unlocking a new era of radiotherapy."
The streamlined workflow of Ethos therapy is enabled by its
AI-driven planning and contouring capabilities. The physician
defines their clinical intent from predefined templates and the
initial treatment plan is generated based on the physician's
intent. The treatment plan is adapted in response to the
variability of the tumor's shape, along with fluctuations in the
tumor's position due to changes in nearby organs. The ability of
Ethos to deliver on-couch adaptive treatment puts the patient at
the center of care.
Ethos therapy offers the use of daily Iterative CBCT imaging and
multimodality images (MR, PET, CT), and at the console. By
providing an up-to-date view of the patient's anatomy, Ethos
therapy provides clinicians the confidence to make more informed
adaptive treatment decisions. The solution is built on Varian's
latest treatment delivery technology and provides fast imaging
and treatment delivery without compromising quality.
Ethos therapy has received CE mark and is currently 510(k)
pending and not for sale in all markets.
For more information on Ethos therapy visit
www.varian.com/ethos
About Varian
At Varian (NYSE: VAR), we envision a
world without fear of cancer. For more than 70 years, we have
developed, built and delivered innovative cancer care technologies
and solutions for our clinical partners around the globe to help
them treat millions of patients each year. With an Intelligent
Cancer Care approach, we are harnessing advanced technologies like
artificial intelligence, machine learning and data analytics to
enhance cancer treatment and expand access to care. Our 9,200
employees across 70 countries keep the patient and our clinical
partners at the center of our thinking as we power new victories in
cancer care. Because, for cancer patients everywhere, their fight
is our fight. For more information, visit
http://www.varian.com and follow @VarianMedSys on Twitter.
Press Contact
Mark Plungy
Director, Global Public Relations
+1 (650) 424-5630
mark.plungy@varian.com
Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
investors@varian.com
View original
content:http://www.prnewswire.com/news-releases/varian-receives-order-for-six-ethos-therapy-solutions-from-amsterdam-umc-in-the-netherlands-300943900.html
SOURCE Varian